Key Record Dates
ClinicalTrials.gov Identifier: | NCT03104413 |
---|---|
Brief Title: | A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment |
First Submitted : | April 4, 2017 |
First Submitted that Met QC Criteria : | April 4, 2017 |
First Posted : | April 7, 2017 |
Results First Submitted : | March 31, 2022 |
Results First Posted with QC Comments : | April 28, 2022 |
Results First Submitted that Met QC Criteria : | May 19, 2022 |
Results First Posted : | June 14, 2022 |
Certification/Extension First Submitted : | July 16, 2021 |
Certification/Extension First Submitted that Met QC Criteria : | May 19, 2022 |
Certification/Extension First Posted : | June 14, 2022 |
Last Update Submitted that Met QC Criteria : | May 19, 2022 |
Last Update Posted : | June 14, 2022 |